Related Experiment Video
Updated: Aug 6, 2026

11:33
Fabrication of Three-dimensional Paper-based Microfluidic Devices for Immunoassays
Published on: March 9, 2017
3D Printed Microfluidic Devices for Integrated Immunoaffinity Extraction, Solid-Phase Extraction, and Fluorescent
James D Holladay1, Zachary A Berkheimer1, Michael K Haggard1
1Department of Chemistry and Biochemistry, Brigham Young University, Provo, Utah 84602, United States.
Precision Chemistry
|May 30, 2025
Summary
Researchers developed a 3D printed microfluidic device for preterm birth (PTB) risk assessment. This integrated platform automates biomarker extraction and labeling, advancing PTB prediction diagnostics.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Point-of-Care Diagnostics
Background:
- Preterm birth (PTB) diagnosis requires complex sample preparation.
- Integrating multiple steps into a single platform is crucial for miniaturized diagnostics.
- Current methods lack the automation needed for rapid PTB risk assessment.
Purpose of the Study:
- To develop a microfluidic device integrating immunoaffinity extraction (IAE) and solid-phase extraction (SPE) for PTB biomarker analysis.
- To demonstrate the device's capability for selective extraction, concentration, and fluorescent labeling of PTB biomarkers.
- To advance the development of a comprehensive microfluidic platform for PTB prediction.
Main Methods:
- Fabrication of a 3D printed microfluidic device incorporating antibody-functionalized IAE and lauryl methacrylate reverse-phase SPE monoliths.
- Utilized 3D printed valves for precise flow control through the extraction monoliths.
- Iterative design process to optimize device functionality for biomarker analysis.
Main Results:
- The device successfully performed selective and reproducible extraction of three PTB biomarkers from buffer and depleted maternal blood serum.
- Demonstrated utility for both single-biomarker and multiplexed extraction strategies.
- Achieved concentrated elution of fluorescently labeled biomarkers, suitable for downstream analysis.
Conclusions:
- The developed microfluidic device effectively integrates orthogonal chromatographic extraction methods.
- This represents a significant advancement towards a complete microfluidic platform for preterm birth prediction.
- The automated sample preparation capabilities pave the way for improved diagnostic tools.
